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OBJECTIVES: The aim of this study was to evaluate systemic inflammatory factors and their relation to success or
failure in a spontaneous ventilation test.
METHODS: This cross-sectional study included a sample of 54 adult patients. Demographic data and clinical
parameters were collected, and blood samples were collected in the first minute of the spontaneous ventilation
test to evaluate interleukin (IL)-1b, IL-6, IL-8, and IL-10, tumour necrosis factor alpha (TNFa) and C-reactive
protein.
RESULTS: Patients who experienced extubation failure presented a lower rapid shallow breathing index than
those who passed, and these patients also showed a significant increase in C-reactive protein 48 hours after
extubation. We observed, moreover, that each unit increase in inflammatory factors led to a higher risk
of spontaneous ventilation test failure, with a risk of 2.27 (1.001 – 4.60, p=0.049) for TNFa, 2.23 (1.06 – 6.54,
p=0.037) for IL-6, 2.66 (1.06 – 6.70, p=0.037) for IL-8 and 2.08 (1.01 – 4.31, p=0.04) for IL-10, and the rapid shallow
breathing index was correlated with IL-1 (r=-0.51, p=0.04).
CONCLUSIONS: C-reactive protein is increased in patients who fail the spontaneous ventilation test, and
increased ILs are associated with a greater prevalence of failure in this process; the rapid shallow breathing
index may not be effective in patients who present systemic inflammation.
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’ INTRODUCTION
The process of discontinuing ventilatory support is referred
to as weaning from mechanical ventilation (MV) and occupies
approximately 40% of the total time spent on MV (1,2). The
most commonly used weaning methods are the spontaneous
ventilation test (SVT) and the use of low support pressures,
both of which reduce the duration of MV and consequently
seem to reduce mortality (2). However, the test used to inter-
rupt MV can result in cardiopulmonary stress and weaning
failure (3), since the transition fromMV to spontaneous breath-
ing results in increased respiratory muscle energy requirements
according to the degree of respiratory overload (respiratory
stress) and the resulting increased oxygen demand, which
lead to increased cardiac output (cardiovascular stress) (4).
The cardiopulmonary stress imposed by the weaning process
induces systemic inflammation through different biological
systems associated with the sympathetic nervous system
and the release of catecholamines, which can influence the
transition process to spontaneous breathing (5,6,7).
A number of studies on the weaning process have estab-
lished a relation between the use of protocols and the success
of this process (8-11). Different protocols are used to clinically
evaluate cardiorespiratory conditions during the SVT in order
to predict the success or failure of this process (8). However,
the relation between the success or failure of MV weaning
and inflammation is unclear. Sellares et al. (5) evaluated
the inflammatory process during the SVT and observed an
increase in the production of IL-6 in patients in whom
weaning failed.
Given that the SVT is stressful, our hypothesis was that
the SVT would be associated with the intensity of systemic
inflammation and thus to a greater probability of failure.
Thus, we decided to analyse the inflammatory blood markers
interleukin (IL)-1b, IL-6, IL-8, IL-10, TNF-a and C-reactive
protein (CRP) in patients submitted to a weaning protocol and
to evaluate the relation between these markers and failure in
this process.DOI: 10.6061/clinics/2018/e256
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’ METHODS
Patients and the mechanical ventilation weaning
protocol
This prospective study was conducted between February
and December 2012 at the Intensive Care Unit (ICU) of
Hospital Moinhos de Vento in Porto Alegre, RS, Brazil. All
patients intubated and mechanically ventilated for more than
48 hours were consecutively included in this study if they
fulfilled the following criteria: improvement or resolution of
the causes that led to acute respiratory insufficiency (ARI);
2) lack of fever (438o) or hypothermia (o35o); 3) haemoglobin
above 9 g/dL; 4) satisfactory neurological status on the
Glasgow Coma Scale (X8) and/or the Richmond Agitation-
Sedation Scale (between -2 and 0) after a pause in sedation
and 5) arterial oxygen pressure (PaO2) above 60 mmHg with
an inspired oxygen fraction (FiO2)p0.4 and positive end-
expiratory pressure between 5 – 8 cmH2O. The exclu-
sion criteria were as follows: 1) tracheostomy; 2) patients
on haemodialysis; 3) neurological alterations; 4) polytrauma;
5) upper digestive haemorrhage; 6) lack of cooperation;
7) decision to limit treatment to life support; and 8) ventila-
tion mode changed to pressure support ventilation, given a
PSp14 cmH2O.
This study was approved by the Hospital Moinhos de
Vento Research Ethics Committee, and because it incurred
no changes to clinical practice and due to the observational
nature of the study, the Hospital Moinhos de Vento ICU
Informed Consent Form was used.
Study protocols
The rapid shallow breathing index (RSBI) and maximal
inspiratory pressure (PImax) were measured in patients meet-
ing the inclusion criteria, and patients presenting RSBIo105
and PImax4-25 cmH2O were considered eligible for the
weaning protocol.
The SVT was conducted for 30 minutes using a T-piece
with supplementary oxygen therapy at 5 L/min. SVT failure
was characterized as a return to invasive ventilatory sup-
port within 48 hours of extubation due to the presence or
persistence of one of the following factors: 1) respiratory
frequency (RF) above 35 breaths per minute; 2) peripheral
oxygen saturation (SpO2) below 90% with FIO2p0.4; 3) heart
rate (HR)4140 and o50 beats per minute; 4) systolic blood
pressure4180 or o70 mmHg; 5) decreased consciousness,
agitation or sweating or 6) paradoxical chest wall motion.
If no signs of SVT failure were evident after 30 minutes,
the patient was extubated. In case of SVT failure, the patient
was reconnected to the mechanical ventilator.
Data collection and definitions
All clinical and chart data relevant to the study were
collected at the beginning and end of the protocol. Patients
fulfilling the inclusion criteria for the weaning protocol
underwent spirometry and manovacuometry.
Respirometry was conducted with a digital pneumotacho-
meter (Ventronic IIs- DHD Healthcare, Wampsville, NY,
USA), which was connected to the patient’s orotracheal tube
(OTT); the patient was then instructed to breathe normally
through the equipment.
Likewise, manovacuometry was performed with an analogue
vacuummanometer (Globalmedsmodel M120, Porto Alegre,
Brasil). The manometer was connected to the patient’s OTT
with a unidirectional valve, and the readings from five
subsequent inspiratory breaths were annotated. The highest
value obtained among the five breaths was considered to be
the PImax.
Analysis of inflammatory factors
An arterial blood sample was collected for the analysis of
arterial gasometry and CRP, whereas a venous sample was
collected to analyse inflammatory factors during the first
minute of the SVT. Blood was collected to evaluate arterial
gasometry and CRP once again 48 hours after extubation for
patients with a successful SVT or at the moment of test
failure for patients without a successful SVT.
For inflammatory factor analysis, blood samples were
centrifuged at 2500 rpm at 4o C for 20 minutes. The sera were
then stored in sterile plastic Eppendorf tubes at -80o C for
subsequent analysis. Cytokine levels were determined with
the ELISA method (Ready-Set-Go!, eBioscience, San Diego,
CA, USA). The following cytokines were evaluated: IL-1b,
IL-6, IL-8, IL-10 and TNF-a, all of which were expressed in
pg/mL, as described previously (5).
Statistical analysis
The convenience sample totalled 54 patients. Statistical
analysis was performed with SPSS 18.0 (SPSS, Chicago, IL,
USA). Data normality was evaluated with the Shapiro-Wilk
test. The numeric variables were expressed as the mean±
standard deviation, and the categorical variables were expres-
sed as the absolute value and percentage. Student’s t-test
was used to compare variables. The Pearson correlation test
was used to evaluate the correlation between inflammatory
variables and CRP. Given that the IL levels were distributed
asymmetrically, these levels were transformed into a loga-
rithm and analysed with a t-test to compare outcomes. A Cox
regression model was used to estimate the factors associated
with SVT failure. The significance level adopted was 5% (po0.05).
’ RESULTS
The general clinical characteristics of the 54 patients
included in the study are summarized in Table 1. In this
population, 34 (63%) passed the SVT and 20 (37%) failed.
Table 1 - Baseline characteristics of the patients.
Characteristics n=54
Gender, male 32 (59%)
Age, years 70±18.02
Weight, kg 73.56±12.69
Height, cm 166.6±16.7
BMI 25.7±4.09
APACHE II score 22.5±6.6
Mechanical ventilation time, days 8.9±1.3
Underlying disease
ARF 37 (68.6)
Sepsis 6 (11.1)
PO 11 (20.4)
Comorbidities
Cardiovascular disease 10 (18.5)
Pulmonary disease 8 (14.8)
Other 27 (50)
No comorbidities 9 (16.7)
Data expressed as n (%) and mean±standard deviation. kg - kilograms;
cm - inches; BMI - body mass index; ARF - acute respiratory failure;
PO - postoperatively.
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Table 2 shows the physiological parameters of the patients
at the beginning of the SVT, indicating who passed and
who failed. When the demographic variables were compared
based on PImax, arterial gasometry, PaO2/FIO2 and cumu-
lative water balance, no significant differences were observed.
However, a significant reduction (p=0.03) was observed
between the RSBI of the group that failed the SVT and the
group that passed. Patients included in the study did not use
vasopressors.
During the first minute of the SVT, there were no dif-
ferences in CRP concentrations between the patients who
failed and those who passed the weaning process. After
48 hours, the CRP levels of patients who failed were signi-
ficantly higher than those during their first minute of the
SVT, which is unlike the CRP levels in patients who passed
the test (Figure 1).
The blood levels of IL-1b, IL-6, IL-8, IL-10 and TNFa were
similar in both groups (Table 3). However, when the RSBI
was evaluated with these factors, it was observed that for
each unit increase in inflammatory factors, there was an
increase in the risk of SVT failure [risk of 2.27 (1.001 – 4.60,
p=0.049) for TNFa, 2.23 (1.06 – 6.54, p=0.037) for IL-6,
2.66 (1.06 – 6.70, p=0.037) for IL-8 and 2.08 (1.01 – 4.31,
p=0.04) for IL-10].
Blood CRP levels correlated with IL-10 levels (r=0.91; po
0.05), as did RSBI values with IL-1 blood levels (r=0.51; po0.05).
’ DISCUSSION
The main finding of this study was that patients who
failed the SVT presented higher inflammatory parameters
than those who passed: 1) the IL levels were higher in
patients who failed the SVT, but only IL-6 levels were
significantly different between the two groups; 2) CRP levels
increased after 48 hours in patients who failed the SVT; and
3) higher levels of TNFa, IL-6 and IL-8 were related to a
higher incidence of SVT failure.
To the best of our knowledge, the relation between
inflammatory markers and SVT failure has been infrequently
studied and is poorly understood. The relationship between
inflammation and the SVT seems to be partly related to the
cardiopulmonary stress of patients during this process (15).
The transition process from MV to spontaneous breathing
could be considered a stress factor due to increased muscle
energy demand and a consequent increase in oxygen con-
sumption, which results in increased cardiac output. This
cardiorespiratory stress could activate different response
systems, including perhaps the sympathetic nervous system.
Activation of this system would result in increased plasmatic
catecholamines, such as IL-6 (17). We observed significantly
higher IL-6 serum concentrations in patients who failed the
SVT than in patients who passed it. This result is similar to
that of Sellares et al. (5), who observed higher IL-6 after the
SVT than the moment before it. Except for IL-6, we found no
significant differences among the other measures in patients
who passed or failed the SVT.
In our study, we observed a 37% failure rate on the
spontaneous breathing test; a similar figure was found in
Table 2 - Comparison of patients with successful SVT with
patients who failed.
Variables Success (34) Failure (20) p
APACHE II score 22.25±7 22.2±6.2 0.97
IRSB 53.97±24.9 46.45±14.03 0.03
MIP, cmH2O 48.02±16.5 46.45±14.03 0.73
pH 7.42±0.07 7.44±0.06 0.29
PaCO2, mmHg 37.6±8.3 42.4±18.1 0.18
PaO2, mmHg 122.4±32.9 117.1±39.1 0.59
PaO2/FiO2 310.5±78.6 301.3±87.7 0.69
Fluid balance, mL 3733.5±1959.5 4051.2±2980.4 0.63
Data expressed as n (%) and mean ± standard deviation. IRSB - index
of rapid shallow breathing; MIP - maximal inspiratory pressure; cmH2O -
centimetres of water; PaCO2 - partial pressure of arterial carbon dioxide;
PaO2 - partial pressure of arterial oxygen.
Table 3 - Evaluation of interleukins (IL) and C-reactive protein
(CRP) in patients with SVT success and failure.
Variables All Success Failure p
IL-1 pg.mL-1 1.22±0.63 1.17±0.64 1.29±0.63 0.56
IL-6 pg.mL-1 1.91±0.35 1.85±0.35 2.06±0.33 0.03
IL-8 pg.mL-1 2.24±0.35 2.18±0.36 2.35±0.33 0.09
IL-10 pg.mL-1 1.65±0.31 1.60±0.22 1.75±0.41 0.08
TNFa pg.mL-1 1.35±0.31 1.27±0.38 1.46±0.37 0.07
CRP mg.dL-1 0.81±0.53 0.72±0.46 0.95±0.62 0.12
Data expressed as n (%) and mean±standard deviation.
Figure 1 - Evaluation of C-reactive protein in patients with success or failure in SVT. * - p=0.032 - comparison of SVT vs. 48h in the failure
group; # - p=0.039 – comparison of 48h success vs. 48h in the failure group;
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the literature, in which failure rates between 20 and 30% have
been reported (2,16).
CRP analysis 48 hours after the SVT showed a significant
increase in this marker both in patients who failed the SVT
and in patients who passed. CRP is an acute phase reactant,
and its plasma level increases four to six hours after a
stimulus, presenting peak concentrations at 36 hours (17).
We suppose that the intensity of the inflammation is due to
cardiovascular stress, such as what occurs in acute exercise.
Exercise induces increased IL-6 levels, which could stimulate
increased CRP, reflecting the intensity of the inflammation
process (18). However, a transitory increase in IL-6 induced
by muscular force for a period of 30-60 minutes seems
to have an inhibiting effect on pro-inflammatory cytokine
activity, particularly on TNFa and IL-1 activity. IL-6 could
trigger a cascade of anti-inflammatory cytokines and receptors,
particularly IL-10 and receptors TNFa and IL-1, which could
subsequently neutralize these potent pro-inflammatory cyto-
kines (19). The study by Toumpanakis et al. hypothesized that
inspiratory resistive breathing (IRB) results in increased
mechanical stress, causing pulmonary inflammation in pre-
viously healthy lungs (20). The authors demonstrated that
cytokines (IL-1 and IL-6) induced MMP-9 expression. In
another study, the authors investigated the differential effects
of IRB, expiratory resistance breathing (ERB) and combined
resistive breathing (CRB). They demonstrated that CRB load
dependently deranges mechanics, increases permeability,
and induces inflammation in healthy rats (21). This finding
could be one possible explanation for the results obtained
by this group, as patients who failed the SVT presented high
IL-6 and increased CRP with no other statistically significant
differences among the other evaluated ILs.
The correlation observed between CRP and IL-10 is
extremely interesting. The inhibitory function of IL-10 on
the production of IL-12 and TNFa by means of activated
macrophages and its inhibition of the expression of
co-stimulators makes IL-10 an important component of
homeostatic control in innate immune reactions and cellular
immunity. Thus, increased CRP, an agent related to increased
inflammatory response, could be associated with an increase
in organic defence by means of IL-10 (22).
We observed, moreover, an inverse correlation between
RSBI and IL-1, which demonstrates that the higher the levels
of systemic IL, the greater the RSBI of patients who undergo
the SVT, clearly showing the influence of inflammation in
this process. Although the inflammatory response is defini-
tively present at the transcriptional level, it is inconsistently
associated with an increase in the cytokine concentration of
bronchoalveolar lavage, and moreover, it is not associated
with changes in pulmonary physiological parameters, which
could be related to evaluation duration, i.e., less than the six
hours, as demonstrated in the abovementioned studies (23).
IL are a diverse group of inflammatory mediators prod-
uced by many types of cells, and they initiate and orchestrate
responses to different stress factors, such as bacteraemia,
shock and thermal injuries. IL act on different types of cells
and can affect all organs in the critically ill from both
a physiological and biochemical point of view, and they
interact with different types of cellular receptors. Although
this interaction occasionally involves a series of intracellular
signals that result in the synthesis of proteins and IL, such as
white blood cells, this process is not regulated and can result
in amplification of the inflammatory cascade and uncon-
trolled activation in immune responses (24,25,26).
This study has certain limitations that should be taken
into consideration, such as the lack of inflammatory analyses
48 hours after extubation and at the end of the SVT, which
could provide pre- and post-test standards for comparison or
late inflammation assessment in these patients.
In our opinion, the present study creates new possibilities
for research into the SVT. The role of the inflammatory
system in patients who undergo this process should be better
explored and clarified.
We can conclude that there is a higher level of CRP in
patients who failed the SVT than in patients who passed it
and higher levels of IL-6 in patients who failed the SVT.
Furthermore, higher TNFa, IL-6 and IL-8 levels are related to
increased incidence of failure.
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